What is the price-to-earnings ratio of Kamada?
The price-earnings ratio of Kamada is currently 5.26.
Kamada P/E 2024
Kamada P/E
5.26
Ticker
KMDA
ISIN
IL0010941198
WKN
A0JMEX
As of Dec 1, 2024, Kamada's P/E ratio was 5.26, a -35.62% change from the 8.17 P/E ratio recorded in the previous year.
The Kamada P/E history
Kamada Aktienanalyse
What does Kamada do?
Kamada Ltd is an Israel-based company specializing in the development and marketing of biopharmaceutical products for humans and animals. The company was founded in 1990 by a team of experienced executives and scientists from the biotech industry. Since its inception, Kamada has become a global leader in plasma fractionation and the production of antibodies and enzymes. The company is listed on the NASDAQ and the Tel Aviv Stock Exchange and has over 450 employees in its facilities in Israel and the USA. Kamada's business model is based on combining innovative science and technology to develop products and therapies for rare and severe diseases. The company is constantly working to improve its production processes to deliver more efficient and cost-effective products. Kamada operates in three divisions: human therapeutics, veterinary medicine, and plasma research. The human therapeutics division develops and markets products for the treatment of diseases such as alpha-1 antitrypsin deficiency, immunoglobulin deficiency, hemophilia, and other serious conditions. The veterinary medicine division offers products for the treatment of diseases in dogs, horses, and cows to veterinary professionals. The plasma research division focuses on developing technologies for the production of plasma derivatives and discovering new applications for plasma proteins. Kamada has a wide range of products on the market, including its flagship product Glassia, which is used to treat alpha-1 antitrypsin deficiency, a rare genetic disease that can affect the lungs. The company also produces intravenous immunoglobulin preparations for the treatment of immune deficiencies and other immune system disorders, as well as recombinant factor VIII for the treatment of hemophilia. In veterinary medicine, Kamada offers products such as Equine Seramune, designed for horses and used to treat life-threatening infections caused by bacteria found in the intestines of horses. The company also produces products for the treatment of mastitis, an infection of the milk ducts in cows, and gastrointestinal tract infections in dogs. Kamada takes pride in playing a leading role in plasma research and technology. The company's research has resulted in groundbreaking technologies that allow for the faster and more cost-effective production of important plasma proteins than was previously possible. Kamada works closely with other research institutions and companies to collaborate on solutions for severe and rare diseases. Over the years, Kamada has received numerous awards and recognition for its groundbreaking research and development work. The company is committed to continuing to develop innovative products and therapies to improve the lives of patients with rare and severe diseases. Overall, Kamada Ltd has experienced remarkable growth in recent years. It is a company that plays a leading role in the market for biopharmaceutical products based on top-notch scientific research and efficient technology. In the future, Kamada will undoubtedly continue to develop groundbreaking products and therapies to improve the lives of patients worldwide. Kamada ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering Kamada's P/E Ratio
The Price to Earnings (P/E) Ratio of Kamada is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing Kamada's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of Kamada is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in Kamada’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about Kamada stock
How has the price-earnings ratio of Kamada changed compared to last year?
The price-to-earnings ratio of Kamada has increased by -35.62% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Kamada high compared to other companies?
Yes, the price-to-earnings ratio of Kamada is high compared to other companies.
How does an increase in the price-earnings ratio of Kamada affect the company?
An increase in the price-earnings ratio of Kamada would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Kamada affect the company?
A decrease in the price-earnings ratio of Kamada would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Kamada?
Some factors that influence the price-earnings ratio of Kamada are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Kamada pay?
Over the past 12 months, Kamada paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Kamada is expected to pay a dividend of 0 USD.
What is the dividend yield of Kamada?
The current dividend yield of Kamada is .
When does Kamada pay dividends?
Kamada pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Kamada?
Kamada paid dividends every year for the past 0 years.
What is the dividend of Kamada?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Kamada located?
Kamada is assigned to the 'Health' sector.
Wann musste ich die Aktien von Kamada kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Kamada from 12/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/1/2024.
When did Kamada pay the last dividend?
The last dividend was paid out on 12/1/2024.
What was the dividend of Kamada in the year 2023?
In the year 2023, Kamada distributed 0 USD as dividends.
In which currency does Kamada pay out the dividend?
The dividends of Kamada are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Kamada
Our stock analysis for Kamada Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kamada Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.